A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Bladder Cancer Patients.

PURPOSE: Poor prognosis of patients with muscle-invasive bladder cancer (BC) that often metastasizes drives the need for discovery of molecular determinants of BC progression. Chondroitin sulfate proteoglycans, including CD44, regulate cancer progression; however, the identity of a chondroitinase (C...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Lokeshwar, Vinata B., Morera, Daley S., Hasanali, Sarrah L., Yates, Travis J., Hupe, Marie C., Knapp, Judith S., Lokeshwar, Soum D., Wang, Jiaojiao, Hennig, Martin, Baskar, Rohitha, Escudero, Diogo O., Racine, Ronny R., Dhir, Neetika, Jordan, Andre R., Hoye, Kelly, Azih, Ijeoma, Manoharan, Murugesan, Klaassen, Zachary, Kavuri, Sravankumar, Lopez, Luis E., Ghosh, Santu, Lokeshwar, Bal L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7334064/
https://ncbi.nlm.nih.gov/pubmed/32094233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-2912
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados